Parabilis Medicines, Inc.
PBLSDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Q2 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
FOG-001 | Phase 2 | Cancer | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Parabilis Medicines, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Parabilis Medicines, Inc.'s (PBLS) pipeline across Phase 2. Its lead program is FOG-001 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Parabilis Medicines, Inc.'s next FDA catalyst?→
Parabilis Medicines, Inc.'s (PBLS) next tracked catalyst is a Phase 2 expected April 1, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PBLS biotech catalysts?→
Add PBLS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Parabilis Medicines, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.